Literature DB >> 26548294

[Nasopharyngeal Hib Carriage Among Healthy Children Attending Daycare Centers in Yokohama After One Year of a Publicly Funded Vaccine Program].

Ayako Saito, Hiroko Sumita, Yutaka Minohara, Shinji Fujita, Shigeyoshi Yazaki, Miyoshi Kitamura, Shigehiko Kawai, Kazumi Kamata, Yoshimi Oota, Mikiko Yamada, Yuko Matsumoto, Nobuaki Takeyasu.   

Abstract

Yokohama city started a regular, free vaccine program for Haemophilus influenzae type b (Hib) from February of 2011. This study was completed to verify the effectiveness of the vaccine on the nasopharyngeal Hib carriage among healthy children attending daycare centers in the Isogo area. The research was conducted during the late spring (Jun--Jul) and fall (Oct-Nov) of 2012. There was a significant decrease in the Hib carriage rate (spring 8.8%, fall 1.6%). During this period there was no increase in the Hib vaccine coverage. The Hib carriage rate of each daycare center was 0-18.4% in spring and 0-4.9% in fall. There was no significant relationship between the rate of non immunized children and that of Hib carriage. This improvement in nasopharyngeal Hib carriage shows the impact of community immunity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26548294     DOI: 10.11150/kansenshogakuzasshi.89.30

Source DB:  PubMed          Journal:  Kansenshogaku Zasshi        ISSN: 0387-5911


  2 in total

1.  Effect of Haemophilus influenzae Type b Vaccination on Nasopharyngeal Carriage Rate in Children, Tehran, 2019.

Authors:  Sedigheh Rafiei Tabatabaei; Sara Mohammadzadeh; Seyed Mohsen Zahraei; Sussan Mahmoudi; Ghazaleh Ghandchi; Seyedeh Mahsan Hoseini-Alfatemi; Abdollah Karimi; Ahmadreza Shamshiri
Journal:  Biomed Res Int       Date:  2021-03-15       Impact factor: 3.411

2.  Public subsidies and the recommendation of child vaccines among primary care physicians: a nationwide cross-sectional study in Japan.

Authors:  Yuta Sakanishi; Yosuke Yamamoto; Megumi Hara; Norio Fukumori; Yoshihito Goto; Tesshu Kusaba; Keitaro Tanaka; Takashi Sugioka; Japan Primary Care Association Vaccine Project Team; Shunichi Fukuhara
Journal:  BMJ Open       Date:  2018-07-19       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.